AutonoMe raises investment to improve employment support for neurodiverse and learning disability people

Posted by 

SETsquared Bristol

AutonoMe has secured over £300k of investment from Ufi Ventures and Bristol City Funds to support scaling up of their employment support programme for neurodiverse people and those with learning disabilities.

AutonoMe is a SETsquared Bristol alumni which blends mobile technology with human support to enable neurodiverse people and those with learning disabilities to develop skills for independent living and employment.

Only 4.8% of people with learning disabilities are currently in employment and while 1 in 7 people are neurodiverse only 22% are in any form of employment.  AutonoMe believes everyone should have equal access to the benefits of meaningful employment.

Its app provides personalised support from an expert dedicated Job Coach alongside employment-related instructional videos. It helps:

  • Develop motivation and resilience for job seeking, and practical and social skills required to secure meaningful paid work.
  • Bespoke training and support tailored to the personalised needs of the learners and their employer, creating the right conditions for sustained employment.
  • Progress proactively monitored to help the learner and employer mitigate any challenges that may arise resulting in long term, sustainable employment outcomes.
  • Employees develop skills and overcome barriers to gain and sustain paid employment whilst employers gain expert support to increase their diversity and inclusivity alongside greater insight into the needs and abilities of their workforce.

Founder and CEO Will Britton said: “The funding and support provided by Bristol City Funds and Ufi Ventures will be instrumental in scaling up our Employment support. Thanks to this investment, we will be able to accelerate our mission to empower neurodiverse people and those with learning disabilities find and sustain meaningful employment as well as to live more independently.”

Recent News, Blogs and Stories

GenomeKey blood sample in lab

Life Sciences spotlight: GenomeKey

Next-generation life sciences company, GenomeKey, was recently awarded $11.4m to transform sepsis diagnosis and treatment. We had a chat with CEO, Dr Michael Roberts, to hear his story… GenomeKey at...
Neuronostics brain EEG graphic showing blue brain waves and human head with brain

Neuronostics forms strategic partnership to deliver integrated EEG solutions for clinical trials 

Neuroelectrics, a pioneer in high-definition brain stimulation and EEG technology, has partnered with Neuronostics, an innovator in advanced digital biomarkers and EEG analysis, to deliver an integrated EEG solution tailored...
Wilder Sensing team of five people in a field with trees

Wilder Sensing secures investment to propel growth and innovation for biodiversity monitoring 

Wilder Sensing, a developer of software for biodiversity monitoring using audio and Artificial Intelligence (AI), has secured £700,000 in equity investment.   The South West Investment Fund awarded £300,000 via...

SUCCESS IS THE GOAL

Fast track your technology business